GE Healthcare has received Food and Drug Administration (FDA) clearance for its Discovery IGS 740, a new rail-free mobile angiography system with a 41x41-cm detector.
It is claimed to be the first of this kind of mobile angiography system in the industry to receive the FDA approval.
The rail-free design allows healthcare professionals ample access to the patient while freeing clinical teams from the constraints of fixed ceiling-mounted system rails.
The system features a wide bore C-Arm and dedicated arm-imaging positions to create ease in imaging the anatomy of interest, and full patient access from the left or right. A rotating laser continuously scans the room so the system knows where it is at all times.
The Discovery IGS 740 incorporates two customizable parking positions to accommodate multiple room sizes and shapes. The 41×41-cm detector enables imaging of large organs, such as the liver and simultaneous coverage of both legs.
The wide-bore C-arm helps interventional radiologist image large patients and to conveniently perform off centered 3D acquisitions.
Additionally, the system is also equipped with more than 20 advanced applications, such as FlightPlan for Liver, which helps clinicians identify tumor-feeding vessels in a few clicks, and be selective during liver embolizations.
GE Healthcare Premium Angiography general manager Chantal Le Chat said the company’s goal is to pioneer a solution designed to free interventional radiologists from traditional constraints.
"With the enhanced mobility of the Discovery IGS 740, clinicians have full freedom to operate, and we believe this can revolutionize the field of interventional imaging," Chat added.